Reher: Counterfeit weight-loss drug crisis looms
Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...
Ozempic Could Be Lifesaving for Thousands of Americans a Year, Study Finds
New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.
Sagimet Soars: FDA Breakthrough Therapy Designation And Lancet Review Validate Denifanstat
Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...
ENDPOINTS NEWS11h
FDA won't take ac­tion against GLP-1 com­pounders as it re­thinks tirzepatide short­age
The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...
Managed Healthcare Executive12h
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...
CDC’s Daskalakis talks bird flu
We spoke with Dr. Demetre Daskalakis, the director of the CDC’s National Center for Immunization and Respiratory Diseases, about the agency’s avian flu response.
Endocrinology Advisor18h
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.
Ozempic could be dished out to help curb boozing and prescription drug addiction
Semaglutide and tirzepatides, the active ingredients in drugs including Mounjaro and Ozempic, have been hailed as a ...
Prescott eNews23h
Pharmacy Leader Warns of Counterfeit Weight-Loss Drug Crisis – Inside Sources
Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...